Royal Fund Management’s Meridian Bioscience Inc VIVO Stock Holding History

Royal Fund Management’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-2,250	Closed	-$18K	–	616
2020 Q1	$18K	Hold	2,250	–	–	0.01%	306
2019 Q4	$21K	Hold	2,250	–	–	0.01%	336
2019 Q3	$21K	Hold	2,250	–	–	0.01%	326
2019 Q2	$26K	Hold	2,250	–	–	0.01%	289
2019 Q1	$39K	Hold	2,250	–	–	0.01%	233
2018 Q4	$39K	Hold	2,250	–	–	0.02%	211
2018 Q3	$33K	Hold	2,250	–	–	0.01%	226
2018 Q2	$35K	Hold	2,250	–	–	0.01%	234
2018 Q1	$31K	Hold	2,250	–	–	0.01%	243
2017 Q4	$31K	Hold	2,250	–	–	0.01%	243
2017 Q3	$32K	Hold	2,250	–	–	0.01%	204
2017 Q2	$35K	Hold	2,250	–	–	0.01%	181
2017 Q1	$31K	Hold	2,250	–	–	0.02%	182
2016 Q4	$39K	Buy	+2,250	New	+$39.5K	0.02%	157

Other funds holding VIVO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Royal Fund Management's VIVO Position: Q2 2020 in Review

Royal Fund Management sold out of Meridian Bioscience Inc (VIVO) in Q2 2020, closing a stake of 2,250 shares — an estimated $18K sold.

Royal Fund Management first reported a position in VIVO in Q4 2016 and held it in 14 quarters. The position peaked at $39K in Q1 2019. 191 funds tracked by Wall St. Rank hold VIVO as of Q2 2020.

Royal Fund Management reported no remaining Meridian Bioscience Inc position as of Q2 2020 after selling out during the quarter.
Royal Fund Management sold 2,250 Meridian Bioscience Inc shares in Q2 2020, an estimated $18K.
Royal Fund Management first reported a position in Meridian Bioscience Inc in Q4 2016 and held it in 14 quarters.
Royal Fund Management's Meridian Bioscience Inc position peaked at $39K in Q1 2019.
191 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2020.

Based on Royal Fund Management's 13F filing for Q2 2020, filed 6 Aug 2020.